Aug 23 (Reuters) -
- RECCE PHARMACEUTICALS COMPLETES STAGE 1 DATA ANALYSIS OF PHASE I/II CLINICAL TRIAL FOR THE TREATMENT OF BURN WOUND INFECTIONS
- RECCE PHARMACEUTICALS LTD - PATIENTS WITH BACTERIAL INFECTIONS SUCCESSFULLY TREATED WITH RECCE 327 (R327)
Aug 23 (Reuters) - RECCE PHARMACEUTICALS COMPLETES STAGE 1 DATA...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $85.06M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.0¢ | $38.76K | 133.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 135000 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 9819 | 2 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |